The human histidine decarboxylase gene is regulated by gastrin through a cis-acting element known as the gastrin response element (GAS-RE) that was initially localized to a site (؉2 to ؉24) downstream of the transcriptional start site. Electrophoretic mobility shift assays using sequentially deleted DNA probes and nuclear extracts from AGS-B gastric cancer cells showed that the GAS-RE is actually composed of two overlapping binding sites (GAS-RE1, ؉1 to ؉19; and GAS-RE2, ؉11 to ؉27) that bind distinct nuclear factors. Reporter gene assays demonstrated that each element alone could confer gastrin responsiveness, but the presence of both elements was required for complete gastrin response. Stimulation of AGS-B cells with gastrin for 10 -20 min resulted in a >2-fold increase in factor binding. The binding was inhibited by pretreatment of AGS-B cells with cycloheximide and the MEK1 inhibitor PD98059, indicating a requirement for protein synthesis and also indicating that activation occurs through the MEK/mitogen-activated protein kinase pathway. UV cross-linking and Southwestern blot analysis showed that GAS-RE1 bound a 52-kDa protein, whereas GAS-RE2 bound a 35-kDa protein. Hence, activation of histidine decarboxylase gene promoter activity by gastrin is most likely mediated by two separate nuclear factors.
Histamine, the major stimulant of acid secretion, is generated in the stomach through the action of the enzyme histidine decarboxylase (HDC) 1 (1) . HDC is expressed at high levels in the enterochromaffin-like cells of the gastric mucosa, where HDC activity is tightly regulated by the level of the circulating peptide hormone gastrin. Binding of the peptide hormone gastrin to the CCK-B/gastrin receptor expressed on enterochromaffin-like cells leads to both histamine secretion and increased histamine production through activation of HDC enzymatic activity. In addition, activation of CCK/gastrin receptor signaling has been shown to lead to increased HDC mRNA abundance. Increased levels of HDC mRNA have been observed in hypergastrinemic rats (2, 3) , and decreased levels of HDC mRNA have been seen in mice with targeted disruption of the genes coding for gastrin or the CCK-B/gastrin receptor (4 -7) .
The stimulation of HDC transcription by gastrin has been shown through experiments involving the transfection of human HDC promoter-luciferase reporter gene constructs into the AGS-B cell line. The AGS-B cell line is a human gastric cancer cell line stably expressing the recombinant human CCK-B/gastrin receptor (3) . The human gastrin receptor is known to be coupled through G proteins to phospholipase C, and gastrin-dependent activation of the CCK-B/gastrin receptor has been shown to induce phosphatidylinositol 4,5-biphosphate hydrolysis, resulting in intracellular Ca 2ϩ mobilization and stimulation of protein kinase C pathways (8, 9) . Recent studies from our laboratory have shown that stimulation by gastrin of AGS-B cells both transiently and stably transfected with the 1.8-kilobase human HDC-luciferase construct leads to an ϳ4-fold increase in promoter activity (10) . In addition, the stimulation of the HDC promoter by gastrin appears to involve a protein kinase C-dependent, MAP kinase/ERK-dependent, and AP-1-dependent pathway (11, 14) . However, whereas in most cases, the transcription factor AP-1 activates cellular promoters by binding to a cis-acting element called the TRE (5Ј-TGACTCA-3Ј), neither the rat nor the human HDC promoter contains a consensus TRE site (3, 10) .
Through deletion analysis of the human HDC promoter, we have recently shown that the cis-acting DNA sequence responsible for gastrin-mediated transactivation is located in a region (ϩ2 to ϩ24) downstream of the transcriptional start site (ϩ1) (10) . This 23-base pair element is called the gastrin response element (GAS-RE). Although the GAS-RE encompasses a larger number of nucleotides than the majority of transcription factor-binding sites, removal of nucleotides from either the 5Ј-or 3Ј-end significantly reduces the response to gastrin (10) . In addition, electrophoretic gel mobility shift assays suggested the presence of only a single delayed complex. Gastrin stimulation of AGS-B cells increases binding of this protein complex to the GAS-RE probe, and competition studies using specific competitors or antibodies indicated that the nuclear factor(s) are most likely novel and do not include AP-1 (Fos/Jun) (10) . However, the precise binding site of the nuclear factor(s) to the GAS-RE was not fully characterized in this initial report.
We have now carried out a more detailed investigation of the GAS-RE, including EMSA experiments with sequentially deleted DNA probes and promoter-luciferase constructs containing various portions of the GAS-RE ligated upstream of the heterologous thymidine kinase promoter. This study suggests that the GAS-RE is in fact composed of two overlapping transcription factor-binding sites (GAS-RE1 and GAS-RE2) that together account for the full transcriptional response to gastrin stimulation through the binding of distinct nuclear factors.
EXPERIMENTAL PROCEDURES
Oligonucleotides and DNA Constructs-A series of oligonucleotides (both sense and antisense) containing gastrin response elements within region Ϫ4 to ϩ27 of the human HDC promoter were used for this study (Table I ). The numbering refers to the position of each nucleotide relative to the transcriptional start site (ϩ1). Additional GAS-RE deletion oligonucleotides similar to those above were synthesized with BamHI and XhoI restriction sites at the 5Ј-end of the sense and antisense oligonucleotides, respectively, for site-specific cloning. Annealed oligonucleotides were ligated upstream of the enhancerless thymidine kinase promoter of herpes simplex virus 1 in the construct pT81 (13) . All constructs were confirmed by sequence analysis. The Gal4-Elk-1 construct contains the Gal4 DNA-binding domain linked to the Elk-1 transactivation domain, and the 5ϫGal-Luc construct contains five consensus Gal4 DNA-binding sites subcloned into p20-Luc (14) .
Cell Culture and Transfections-AGS-B cells (3) were grown and maintained in Dulbecco's modified Eagle's Medium (Whittaker Inc., Walkersville, MD) supplemented with 10% fetal bovine serum, 100 IU/ml penicillin, and 100 g/ml streptomycin in a humidified atmosphere of 5% CO 2 and 95% air. Cells were transfected with 0.5 g of plasmid/well in a six-well tissue culture plate by the calcium phosphate precipitation method (DNA transfection kit, 5 Prime 3 3 Prime, Inc., Boulder, CO). Cells were stimulated with gastrin 24 h post-transfection under serum-free conditions, and luciferase assays were done at 48 h. Relative induction (-fold increase) by gastrin was calculated by taking the ratio of luciferase activity in the presence of gastrin compared with luciferase activity in the unstimulated control. Results represented the mean Ϯ S.E. of three independent experiments. When necessary, cells were serum-starved for 48 h in ultraculture medium, followed by stimulation with gastrin (10 Ϫ7 M) for different time periods prior to preparation of nuclear extracts. In some experiments, serum-starved cells were incubated with 10 or 25 g/ml cycloheximide (Sigma) for 1 and 2 h, respectively, or with 30 M/ml MEK1 inhibitor (PD98059, New England Biolabs Inc.) for 5 h prior to stimulation with gastrin (10 Ϫ7 M) for 20 min. In cotransfection experiments performed with Gal4-Elk-1 and 5ϫGal-Luc constructs, transfected cells were pretreated with cycloheximide (10 g/ml) for 1 h prior to stimulation (with gastrin or PMA), and responsiveness was calculated as -fold increase in luciferase activity compared with untreated controls.
Electrophoretic Mobility Shift Assays-Nuclear extracts were prepared from a variety of cell lines as described previously (3, 10) and used in EMSAs. These cell lines included the following: AGS-B, a human gastric cancer cell line expressing the recombinant CCK-B/gastrin receptor (either stimulated with gastrin or unstimulated); AGS-0, human gastric cancer cells; COS-7, monkey kidney cells; BON, human pancreatic cells; KATO-3, human gastric carcinoma cells; PC12, rat pheochromocytoma cells; and S2, Schneider's Drosophila cells. Double-stranded oligonucleotides were radiolabeled with [␣-32 P]dCTP, and EMSAs were performed with 5 g of nuclear extracts in a final volume of 20 l in binding buffer containing 10 mM Tris-Cl (pH 7.5), 50 mM NaCl, 5 mM MgCl 2 , 1 mM dithiothreitol, 1 mM EDTA, 1 g of poly(dA-dT), and 10% glycerol. Mixtures were incubated with 10 fmol of double-stranded oligonucleotide probes for 20 min at room temperature. DNA-protein complexes were electrophoresed on a 6% nondenaturing polyacrylamide gel containing 0.25ϫ Tris borate/EDTA at a constant current of 15 mA. Gels were dried and exposed to Eastman Kodak X-AR film for appropriate times at room temperature. For competition experiments, nuclear extracts were incubated with up to 100-fold excess of competitor double-stranded oligonucleotides at room temperature for 10 min before addition of the radiolabeled probe. For gastrin stimulation assays, the density of the resulting bands was determined using a Molecular Dynamics personal densitometer with ImageQuant Version 3.22 software (Molecular Dynamics, Inc., Sunnyvale, CA).
UV Cross-linking-Four sets of double-stranded oligonucleotides for UV probes GAS-RE1 WT, GAS-RE1 M1, GAS-RE2 WT, and GAS-RE2 M2 were Klenow end-labeled in the presence of bromodeoxyuridine. Crude nuclear extracts from AGS-B cells were incubated with probes in EMSA binding buffer for 30 min on ice, followed by exposure to UV light (312 nm) for 20 min. After UV cross-linking, the DNA-protein complexes were boiled for 5 min with 2ϫ SDS sample buffer and electrophoresed on a 12% SDS-polyacrylamide gel with 1ϫ Tris/glycine electrophoresis buffer containing 25 mM Tris, 200 mM glycine (pH 8.3), and 0.1% SDS. Prestained molecular mass markers were used to calculate the molecular mass of the proteins. Gels were dried and exposed to Kodak X-AR film at Ϫ80°C.
Southwestern Blotting-Nuclear extracts from AGS-B cells were prepared and quantitated. For each lane, 50 g of nuclear extracts were mixed with 2ϫ SDS sample buffer, heated at 95°C for 5 min, and electrophoresed on a polyacrylamide gel. Prestained protein molecular mass markers were run to monitor electrophoretic transfer and to determine relative size (kilodaltons). Transfer to Hybond-ECL nitrocellulose membrane was done for 90 min at room temperature in a TransBlot apparatus (Bio-Rad) at 200 mA with a buffer containing 25 mM Tris, 200 mM glycine, and 20% methanol. After transfer, the blots were air-dried and subjected to the following procedure directly without performing guanidine hydrochloride denaturation/renaturation steps. After pretreatment with a solution of blocking buffer containing 3% nonfat dry milk and 1 g/ml poly(dI-dC) for at least 1 h, blots were probed for 1 h with radioactive GAS-RE1 and GAS-RE2 in binding 
GATCCAGGGCCCACACTGG buffer. Blots were washed with three changes of binding buffer over a period of 15 min, air-dried, and autoradiographed on Kodak X-AR film.
RESULTS

Identification of Two Overlapping Nuclear Factor-binding Regions in the HDC
Promoter-In our initial study, we found that the HDC promoter sequence responsible for gastrin-stimulated transactivation could be localized to a region (ϩ2 to ϩ24) downstream of the transcriptional start site (10) . The entire 23-nucleotide sequence appeared to be essential for gastrin responsiveness inasmuch as removal of a few nucleotides at either the 3Ј-or 5Ј-end reduced gastrin responsiveness substantially (10). This region was also capable of relative high affinity binding to factors present in AGS-B nuclear extracts. To characterize the nucleotides essential for DNA binding, block mutagenesis (5 nucleotides/block) was performed on a ϩ1/ϩ27 labeled HDC probe, and factor binding was assessed using the EMSA. Surprisingly, a single block mutation of the ϩ1/ϩ27 sequence was not able to block binding entirely (data not shown). In contrast, all five sets of block mutations reduced responsiveness to gastrin and PMA when cloned upstream of the minimal thymidine kinase promoter-luciferase construct (data not shown). Since it appeared that there were mutations at either end of the DNA response element that reduced promoter responsiveness to gastrin but that did not inhibit factor binding entirely, this suggested to us the possibility of cooperative interactions between overlapping binding motifs.
To identify these overlapping binding motifs, we carried out EMSA analysis using serial 5Ј-and 3Ј-deletions of our HDC gel shift probe. We started with the larger ϩ1/ϩ27 HDC probe since it appeared to show greater binding than the ϩ2/ϩ24 probe in EMSAs. Deletion from the 5Ј-end showed that the ϩ11/ϩ27 sequence still maintained significant binding, whereas deletion from the 3Ј-end showed that the ϩ1/ϩ19 sequence also retained significant binding (data not shown). Further deletions of these minimal elements led to substantial decreases in binding in EMSAs. Deletion of nucleotides from either end of the ϩ1/ϩ19 (Fig. 1A) or ϩ11/ϩ27 (Fig. 1B) HDC probe reduced binding significantly. The ϩ3/ϩ19 probe bound a complex with an altered mobility, raising the possibility of either altered probe conformation (such as interruption of a palindromic structure) or binding of different protein factors (Fig. 1A) . Decreased binding was seen with the ϩ1/ϩ17 probe, and no binding was observed with the ϩ8/ϩ19 probe (Fig. 1A) . In the case of the downstream element (ϩ11 to ϩ27), decreased binding was observed as the 3Ј-end was gradually deleted down to ϩ24, and no binding was observed with the ϩ11/ϩ22 probe (Fig. 1B) . Decreased binding was also noted with removal of 3 nucleotides from the 5Ј-end with the ϩ14/ϩ27 probe (Fig. 1B) .
Overall, these EMSA deletion experiments indicate at least two separate DNA-binding motifs, which we designated GAS-RE1 (ϩ1 to ϩ19) and GAS-RE2 (ϩ11 to ϩ27). Whereas competition with either GAS-RE1 or GAS-RE2 alone was not able to eliminate binding to the GAS-RE (ϩ1 to ϩ27), competition with an excess of unlabeled oligonucleotides containing both sequences (i.e. ϩ1 to ϩ27) was able to reduce binding entirely (Fig. 1C) .
EMSA Experiments Demonstrate That GAS-RE1 and GAS-RE2 Bind Distinct Nuclear Factors-Since the gel shift complexes binding to GAS-RE1 and GAS-RE2 appeared to migrate in a similar pattern and location in EMSAs (Fig. 1C) , the possibility existed that the two cis-acting elements bound to identical or closely related nuclear factors. Consequently, we carried out cross-competition experiments using either the GAS-RE1 (ϩ1 to ϩ19) or GAS-RE2 (ϩ11 to ϩ27) sequence as a DNA probe and also as an unlabeled competitor (Fig. 2) . When GAS-RE1 was used as a labeled probe, GAS-RE2 competed, but to a much lesser extent than GAS-RE1 ( Fig. 2A) . Similarly, when GAS-RE2 was used as a labeled probe, GAS-RE1 competed, but again to a much lesser extent than GAS-RE2 (Fig.  2B) . In each case, complete competition could be seen with a 100-fold excess of the corresponding wild-type probe, whereas only partial competition could be seen with a 100-fold excess of the non-identical probe.
To identify the exact nucleotides with each DNA element required for factor binding, scanning mutagenesis was performed using 5-block nucleotide substitutions in GAS-RE1 and GAS-RE2. Double-stranded wild-type or mutant oligonucleotides were used either as labeled probes in the EMSA (Fig. 3, A  and B) or as unlabeled competitors (Fig. 3, C and D) . In the case of GAS-RE1 (ϩ1 to ϩ19), the M1 mutation, changing ϩ2 CCCTT ϩ6 to ϩ2 AAGAA ϩ6 , profoundly reduced binding to the labeled probe (Fig. 3A) or markedly reduced the degree of competition (Fig. 3B) . In the case of GAS-RE2 (ϩ11 to ϩ27), the M2 mutation, changing ϩ16 GGCC ϩ19 to ϩ16 CAAT ϩ19 , eliminated binding to the labeled probe (Fig. 3C ) and eliminated Ϫ7 M gastrin and incubated with double-stranded DNA probes representing the human HDC promoter elements as listed. Complexes were resolved on nondenaturing polyacrylamide gels. Bound complexes are indicated with an arrow. A, GAS-RE1 (ϩ1 to ϩ19) and deletions; B, GAS-RE2 (ϩ11 to ϩ27) and deletions; C, GAS-RE (ϩ1 to ϩ27) used as a probe in EMSA, with or without gastrin stimulation (10 Ϫ7 M for 20 min) and competition with unlabeled competitors (100-fold). Specific complexes are indicated with an arrow. competition when used as an unlabeled competitor (Fig. 3D) . Thus, these mutational studies indicate that the nuclear factors bind GAS-RE1 and GAS-RE2 in a sequence-specific fashion and recognize distinct DNA sequences.
Gastrin Stimulation Results in Rapid Increases in Binding of Novel Nuclear Factors to GAS-RE1 and GAS-RE2-Stimulation of AGS-B cells with maximal effective concentrations of gastrin (10 Ϫ7 M) led to increased factor binding to the entire GAS-RE (ϩ1 to ϩ27) with 20 min of stimulation (Fig. 1C) . To examine the time course and to determine whether this stimulation held true for both GAS-RE1 and GAS-RE2, EMSA studies were repeated using the separate elements as probes. Gastrin stimulation led to increased factor binding to GAS-RE1 and GAS-RE2 as early as 10 min after stimulation (Fig. 4) . Examination of extracts after 3 and 5 min of gastrin stimulation showed no increase in factor binding at these earlier time points (data not shown). The intensity of the complexes reached a maximum at 20 min for GAS-RE2 and 40 min for GAS-RE1, but remained elevated for up to 60 min for both factors (Fig. 4,  C and D) . Scanning densitometric analysis indicated that gastrin stimulation led to maximal increases in binding of 2.9-fold for GAS-RE1 (at 40 min) and 2.3-fold for GAS-RE2 (at 20 min) (Fig. 4, A and B) .
An extensive Internet-based homology search was done to compare the GAS-RE1 and GAS-RE2 promoter sequences with known transcription factor-binding sites. No homology to a known binding motif was found in our search. Since gastrin has been shown to stimulate HDC promoter activity through a MAP kinase/ERK-related pathway, we performed EMSA competition using as unlabeled competitors binding motifs for transcription factors known to be activated by MAP kinase, including AP-1, AP-2, AP-3, SP-1, EGR-1, CRE, and SRE. Although GAS-RE1 and GAS-RE2 were competed away by a 100-fold excess of wild-type competitors, they were not competed away by DNA sequences representing these known transcription factor-binding motifs (data not shown). The expression of these novel transcription factors was not restricted to gastric cells (Fig. 5, A and B) ; rat PC12 and Drosophila S2 cells did not appear to express these factors, although this may be due to species differences.
Full Gastrin Responsiveness Requires Intact GAS-RE1 and GAS-RE2-To confirm that GAS-RE1 and GAS-RE2 each contribute to gastrin responsiveness by the HDC promoter, we generated a series of heterologous promoter constructs in which various HDC promoter sequences were cloned upstream of the herpes simplex virus 1 thymidine kinase promoter in the pT81 luciferase construct (Fig. 6 ). Fig. 6A shows the effect on basal promoter activity. Both GAS-RE1 (ϩ1 to ϩ19) and GAS-RE2 (ϩ11 to ϩ27) resulted in significant (10-fold) increases in basal promoter activity, whereas two copies (2C) of each element resulted in only slightly greater enhancer activity compared with a single copy. In contrast, the full-length GAS-RE (ϩ1 to ϩ27) gave a much greater enhancer response (nearly 30-fold) than either element alone (Fig. 6A) . Deletion of the full-length GAS-RE at either the 5Ј-or 3Ј-end resulted in a significant loss of enhancer activity. Single mutations (M) in either GAS-RE1 or GAS-RE2 reduced enhancer activity, whereas double mutations (DM; M1 in GAS-RE1 plus M2 in GAS-RE2) in the ϩ1/ϩ27 GAS-RE element completely eliminated enhancer activity (Fig. 6A) .
In terms of gastrin responsiveness, the ϩ1/ϩ27 element gave the greatest (4.3-fold) response to gastrin, which was much greater than that observed with the previously identified GAS-RE (ϩ2 to ϩ24), which gave only a 2.2-fold response (Fig.  6B) . Deletion of the full-length GAS-RE (ϩ1 to ϩ27) at the 5Ј-end (to ϩ2, ϩ3, and ϩ8) significantly reduced gastrin responsiveness. Nevertheless, the ϩ11/ϩ27 element still showed a 2.7-fold response to gastrin, and two copies of the ϩ11/ϩ27 element gave a 3.6-fold response to gastrin. Deletion of the ϩ11/ϩ27 element at the 3Ј-end to ϩ11 to ϩ22 reduced gastrin responsiveness close to that of pT81 (1.7-fold). The ϩ1/ϩ19 element gave a 3.5-fold response to gastrin, which was increased only slightly by addition of a second copy (Fig. 6B) . Mutation of the ϩ1/ϩ19 element (M1) reduced gastrin responsiveness by 80%, whereas mutation of the ϩ11/ϩ27 element (M2) also reduced gastrin responsiveness by 80%. Mutations of both elements (M1 and M2) completely eliminated gastrin responsiveness by the ϩ1/ϩ27 construct (Fig. 6B) . Thus, these functional studies confirm that each element (GAS-RE1 and GAS-RE2) contributes to the gastrin responsiveness by the HDC promoter, but that full responsiveness requires both elements.
Gastrin Stimulation of Factor Binding Requires New Protein Synthesis and Activation of the MAP Kinase Pathway-
The above experiments have demonstrated that gastrin stimulation leads to increased factor binding to GAS-RE1 and GAS-RE2. To   FIG. 2 . Electrophoretic mobility shift assays showing little cross-competition between GAS-RE1 and GAS-RE2. A, nuclear extracts prepared as described in the legend to Fig. 1 were incubated with the GAS-RE1 probe (ϩ1 to ϩ19) and competed with wild-type competitor (100-fold) or with various concentrations of GAS-RE2 (ϩ11 to ϩ27). B, nuclear extracts were incubated with GAS-RE2 (ϩ11 to ϩ27) as a probe and competed with wild-type competitor (100-fold) or with various concentrations of GAS-RE1 (ϩ1 to ϩ19).
determine whether gastrin stimulation of factor binding requires new protein synthesis, we incubated serum-starved AGS-B cells with cycloheximide for either 1 or 2 h. Pretreatment of AGS-B cells with cycloheximide at a dose of 25 g/ml for 1 h had little effect on basal binding, but inhibited induction of factor binding to GAS-RE1 (Fig. 7A ) and GAS-RE2 (Fig. 7B) . Identical results were obtained when cycloheximide was used at a dose of 10 g/ml (data not shown). When AGS-B cells were pretreated with cycloheximide at a dose of 25 g/ml for 2 h, gastrin induction of factor binding was inhibited, but basal factor binding was also reduced (Fig. 7, A and B) .
Previous studies have indicated that gastrin-mediated activation of HDC transcription occurs through an ERK-dependent pathway (14) . To examine the role of the ERK pathway in factor binding to GAS-RE1 and GAS-RE2, we pretreated cells with the MEK1 inhibitor PD98059 prior to gastrin stimulation. Under these conditions, gastrin was unable to stimulate factor binding to GAS-RE1 and GAS-RE2 (Fig. 8, A and B) , indicating a key role for the MEK1/ERK pathway in activating these transcription factors. MEK1 inhibitor pretreatment of AGS-B cells transfected with luciferase reporter gene constructs also blocked 58% of the HDC promoter activation by gastrin stimulation (data not shown).
To determine whether the effect of cycloheximide was upstream or downstream of the ERK pathway, we tested the effect of protein synthesis inhibition on the Gal4-Elk-1 system. AGS-B cells were cotransfected with 2.0 g of the Gal4-Elk-1 expression construct along with the 5ϫGal-Luc reporter construct. Cells were incubated with or without cycloheximide (10 g/ml) for 1 h prior to either gastrin or PMA stimulation (10 Ϫ7 M), and luciferase activity was measured. Preincubation with cycloheximide decreased activation of Gal4-Elk-1 by PMA from 15-to 2.2-fold and by gastrin from 2-to 1.5-fold, consistent with an inhibitory effect on ERK activation.
GAS-RE1 and GAS-RE2 Bind 52-and 35-kDa Factors, Respectively-To investigate the size of the nuclear factors that bind the GAS-RE1 and GAS-RE2 sequences, we performed UV cross-linking studies using bromodeoxyuridine-substituted probes. The radiolabeled, bromodeoxyuridine-substituted probes were incubated with AGS-B nuclear extracts, exposed to UV light (312 nm), and then resolved on a 12% SDS-polyacrylamide gel. Mutant probes were used to assess the specificity of FIG. 3 . EMSA analysis with mutant probes demonstrates sequence-specific binding. Mutational analysis of GAS-RE1 and GAS-RE2 revealed the key nucleotides involved in nuclear factor binding in electrophoretic mobility shift assays. A, wild-type and mutant GAS-RE1 (ϩ1 to ϩ19) sequences used as DNA probes; B, wild-type and mutant GAS-RE2 (ϩ11 to ϩ27) sequences used as DNA probes; C, wild-type GAS-RE1 (ϩ1 to ϩ19) used as a DNA probe and wild-type or mutant GAS-RE1 sequences used as unlabeled competitors; D, wild-type GAS-RE2 (ϩ11 to ϩ27) used as a DNA probe and wild-type or mutant GAS-RE2 sequences used as unlabeled competitors.
binding. Molecular masses for nuclear factors were calculated after subtracting the molecular mass of the oligonucleotide probes. As shown in Fig. 9A , the GAS-RE1 wild-type probe bound a 52-kDa factor that was not observed with the mutant M1 probe. The GAS-RE2 (ϩ11 to ϩ27) wild-type probe bound a 35-kDa factor that was not seen with the mutant M2 probe (Fig. 9B) .
Southwestern blot analysis was performed as described previously (15) to confirm the UV cross-linking data (Fig. 10) . Equivalent amounts (ϳ50 g) of crude nuclear extracts from AGS-B cells were resolved by SDS-polyacrylamide gel electrophoresis and transferred by a Western blot technique to nitrocellulose filters. After transfer, the blot was cut into two identical strips, each containing a lane of AGS-B proteins. Blots were probed with three copies of either the GAS-RE1 (Fig. 10A) or GAS-RE2 (Fig. 10B) wild-type probe. These studies showed a single complex that could be observed with these probes. No complex was observed when mutant probes were used (data not shown). Comparison to size markers showed that the GAS-RE1 sequence bound a 52-kDa protein, whereas the GAS-RE2 sequence bound a smaller, 35-kDa protein.
DISCUSSION
In this study, we have shown that at least two nuclear factors are responsible for mediating gastrin responsiveness by the human HDC promoter: GAS-REBP1 and GAS-REBP2. Our previous report noted only one nuclear complex binding to the GAS-RE (10), but further deletion and mutational analysis of the human HDC promoter has now revealed overlapping DNAbinding sites (ϩ1 to ϩ19 and ϩ11 to ϩ27) that bind nuclear factors with distinct sizes and binding specificity. Each of these elements was shown to behave as a true enhancer when ligated upstream of a heterologous promoter, and full gastrin responsiveness required both cis-acting elements. Block mutations in minimal sequence motifs (CCCTT in GAS-RE1 and GGCC in GAS-RE2) that led to a reduction in promoter activity also were sufficient to abolish binding in gel mobility shift assays, UV cross-linking, or Southwestern blot assays. In addition, we have shown that gastrin stimulation led to a rapid increase in factor binding to both DNA elements; increased binding in FIG. 4 . Gastrin stimulation results in increased factor binding to both GAS-RE1 and GAS-RE2. AGS-B cells were serum-starved for 48 h and stimulated with gastrin (10 Ϫ7 M) for 10 -60 min. Crude nuclear extracts were prepared and incubated with labeled DNA probes representing GAS-RE1 (ϩ1 to ϩ19) (A and C) and GAS-RE2 (ϩ11 to ϩ27) (B and D). A and B show the results of scanning densitometry, and C and D show the EMSA gels. hHDC, human HDC.
FIG. 5. Distribution of GAS-RE1 and GAS-RE2 in different cell lines.
Crude nuclear extracts (5 g) were prepared from a number of different cell lines (described under "Experimental Procedures") and analyzed in EMSAs using as a labeled probe either GAS-RE1 (ϩ1 to ϩ19) (A) or GAS-RE2 (ϩ11 to ϩ27) (B). Specific complexes are indicated with an arrow.
EMSA could be observed as early at 10 min post-gastrin stimulation, with near maximal increases occurring at 20 min postgastrin stimulation.
Gastrin is a peptide hormone that is known to regulate a number of gastric functions (including acid secretion) through binding to the CCK-B/gastrin receptor, but downstream targets of gastrin-regulated signaling pathways, such as transcription factors, have not been as well defined. In addition to regulating HDC gene expression, gastrin has also been reported to activate the transcription of a number of growth factor-related genes, including c-fos, c-jun, and c-myc (16, 17) . Activation of c-fos transcription in AR4-2J cells appears to proceed through a MAP kinase pathway (17) . Gastrin has also been shown to stimulate translation of genes such as ornithine decarboxylase through a rapamycin-sensitive pathway possibly involving p70 S6K and 4E-BP1 (18) . The mechanisms of transcriptional activation by gastrin of cell-specific genes such as chromogranin A (19), vesicular monoamine transporter-2 (20) , and HDC (3, 10), which in the gastric mucosa are expressed primarily in enterochromaffin-like cells, have not been as thoroughly characterized. We have recently shown that HDC transcription is activated by gastrin through an ERK-dependent pathway that requires protein kinase C and Raf-1, but that does not require Ras (11) . The HDC promoter can also be activated by oxidative stress (H 2 O 2 ) through the GAS-RE and an ERK-dependent pathway that requires Ras (21) . We now report that activation by gastrin of putative transcription factor complexes GAS-REBP1 and GAS-REBP2 requires an intact MEK1/MAP kinase pathway. PD98059, a highly selective inhibitor of MEK1 activation, completely inhibited the increase in factor binding to GAS-REs observed after gastrin stimulation. However, activation of the GAS-REBPs did not appear to occur solely through a post-translation event (e.g. phosphorylation). Pretreatment of FIG. 6 . Reporter gene studies show that both GAS-RE1 and GAS-RE2 are required for full gastrin responsiveness. A series of deletion fragments of the human HDC promoter containing putative gastrin response elements were ligated upstream of the enhancerless thymidine kinase promoter in the vector pT81. These human HDCpT81 constructs were transfected into AGS-B cells, and gastrin (10 Ϫ7 M) responsiveness was assessed as absolute luciferase counts (A) or -fold increase in activity compared with unstimulated control (B). A shows the results of basal (unstimulated) activity, and B shows the gastrin response of the same constructs. Results represent the mean Ϯ S.E. of three independent experiments. M, mutant; 2C, two copies; DM, double mutant.
FIG. 7.
Cycloheximide blocks factor binding to GAS-RE1 and GAS-RE2. AGS-B cells were serum-starved for 48 h, treated with 25 g/ml cycloheximide for 1 or 2 h, and stimulated with gastrin (10 Ϫ7 M) for 20 min. Crude nuclear extracts were prepared from both gastrinstimulated and unstimulated cells for EMSAs using radiolabeled probes: GAS-RE1 (A) and GAS-RE2 (B).
AGS-B cells with cycloheximide resulted in marked inhibition of factor binding in response to gastrin stimulation, suggesting that new protein synthesis (perhaps of the GAS-REBPs) was also required. However, cycloheximide also inhibited gastrinand PMA-mediated activation of Gal4-Elk-1, suggesting that the cycloheximide block may occur upstream of ERK activation in this system. Clearly, further studies will be required to determine whether gastrin-dependent HDC promoter activation actually requires increased production of the GAS-REBP factors.
The gastrin response elements (GAS-RE1 and GAS-RE2) in the HDC promoter appear to represent novel transcription factor-binding sites. EMSA competition using double-stranded oligonucleotides representing known transcription factor-binding motifs yielded no useful clues as to the identity of the two factors. In addition, Internet-based TESS searches (12) showed no homology to any of the published transcription factor-binding sites. UV cross-linking and Southwestern blot assays showed that GAS-REBP1 is a 52-kDa protein, whereas GAS-REBP2 is a 35-kDa protein. Although a number of known transcription factors have reported in these size ranges, none appears to have similar specificity for these DNA sequences. The GAS-RE2 sequence, while GC-rich, does not bind a zinc finger as shown by lack of effect of EGTA chelation on binding (data not shown). Deletion studies with the GAS-RE1 sequence raise the possibility of a palindromic secondary structure since deletions that might be predicted to alter such structure lead to altered migration in EMSAs (Fig. 1A) . Since the two GAS-REs FIG. 8 . MEK inhibition blocks factor binding to GAS-RE1 and GAS-RE2. AGS-B cells were serum-starved for 48 h and incubated with 30 M/ml MEK1 inhibitor (PD98059) for 5 h prior to stimulation with gastrin (10 Ϫ7 M) for 20 min. Crude nuclear extracts were incubated with radiolabeled probes (GAS-RE1 (A) and GAS-RE2 (B)) for EMSA.
FIG. 9.
UV cross-linking of GAS-REBP1 and GAS-REBP2. Crude nuclear AGS-B extracts were incubated with bromodeoxyuridine-substituted probes, followed by UV exposure and separation on SDS-polyacrylamide gels (see "Experimental Procedures"). A, GAS-RE1 (ϩ1 to ϩ19) wild-type and mutant probes; B, GAS-RE2 (ϩ11 to ϩ27) wild-type and mutant probes. Positions of the UV-cross-linked protein bands are indicated by arrows. Positions of the prestained molecular mass markers (in kilodaltons) are shown. FIG. 10 . Southwestern blot analysis. 50 g of nuclear extracts made from AGS-B cells were electrophoresed and transferred to Hybond-ECL nitrocellulose membrane. Blots were blocked and probed with GAS-RE1 (A) and GAS-RE2 (B).
appear to have additive effects in terms of both basal promoter activity and transcriptional activation in response to gastrin stimulation, we believe that they may bind the nuclear factors GAS-REBP1 and GAS-REBP2 in some sort of cooperative fashion, although we cannot at this time completely exclude the possibility of competitive interactions.
In summary, the nuclear factors GAS-REBP1 and GAS-REBP2 appear to represent novel regulators of HDC gene expression and mediate the transcriptional responses to CCK-B/gastrin receptor activation. In addition, as downstream targets of the MEK/MAP kinase pathway and factors that are expressed in many cell types (10), the GAS-REBPs may be involved in the regulation of other growth-related genes. Additional insight into the biology of the GAS-REBPs will most likely await further identification and characterization of the two factors, which, given our above results, may be possible through purification or affinity cloning techniques.
